Organ Donation from Donors with Hepatitis B or C in South Korea: A 2013-2017 Nationwide Data Analysis

Hoonsung Park1, Eun-Sil Jung2, Myoung Hwa Lee3

  • 1Department of Surgery, Korea University Medical Center, Korea University College of Medicine, Seoul, South Korea.

Insights

Organ donation from hepatitis B (HBV) and C (HCV) positive brain-dead donors is limited in South Korea. Recipient refusal and donor unsuitability are key barriers to successful transplantation.

Area of Science:

  • Transplantation immunology
  • Hepatology
  • Public health

Background:

  • Organ donation from hepatitis B (HBV) and hepatitis C (HCV) virus carriers is increasing.
  • Data on organ donation from brain-dead donors with hepatitis in South Korea is limited.
  • Analysis of organ donation from brain-dead donors with hepatitis is crucial for improving transplant rates.

Purpose of the Study:

  • To analyze the current status of organ donation from brain-dead donors with hepatitis B or C in South Korea.
  • To identify barriers to successful organ transplantation from hepatitis carriers.
  • To propose strategies for increasing organ donation from HBV/HCV-positive donors.

Main Methods:

  • Retrospective analysis of brain death reports and organ transplantation data in South Korea (2013-2017).
  • Inclusion of 9210 potential brain deaths, with 333 identified as hepatitis carriers (HBV/HCV).
  • Examination of 2460 completed transplantations, including 71 from hepatitis carriers.

Main Results:

  • 60 and 11 transplantations were completed from HBV- and HCV-positive brain-dead donors, respectively.
  • Primary reasons for transplantation failure included recipient refusal (n=90) and donor unsuitability (n=80).
  • Kidney and liver donations were most common (71 and 31, respectively); HBV donors provided more organs on average than HCV donors.

Conclusions:

  • Organ donation from brain-dead donors with hepatitis B or C leading to successful transplantation is infrequent in South Korea.
  • Recipient refusal and donor unsuitability due to active viral conditions are major obstacles.
  • Strategies to promote transplantation include recipient education, post-transplant infection management protocols, and enhanced medical staff training.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
109
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
620
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
675